ISOThrive Inc.
HEALDSBURG, CA · CIK 0001793898 · Biotech · Private
Digestion-resistant carbohydrates targeting specific bacteria to correct microbiome dysbiosis
pharma.isothrive.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $17M
- 3 Form D · Nov 2025
- 11 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 11
- 6 granted · 5 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20192020202120222023202420252026
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $4,029,054 | |
| Private capital raised | Form D · SEC | $5,200,003 | |
| Private capital raised | Form D · SEC | $8,136,598 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1171 | Nova Mentis Life Science Corp. | — | $188K |
| 1172 | SCYNEXIS, INC. | — | $5.5M |
| 1173 | MediSix Therapeutics, Inc. | — | $35M |
| 1174 | ISOThrive Inc. | — | $17M |
| 1175 | Unleash Immuno Oncolytics, Inc. | — | $3.0M |
| 1176 | Cessation Therapeutics, Inc. | — | $6.8M |
| 1177 | Dnalite Therapeutics, Inc. | — | $5.6M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- James FarrellDirector
- JAMES FARRELLDirector
- Fadi KaramDirector
- FADI KARAMDirector
- Jack OswaldDirector · Executive Officer
- Alyn OswaldDirector
- JACK OSWALDDirector · Executive Officer
- ALYN OSWALDDirector · Executive Officer
- Mike WaltherDirector
- MIKE WALTHERDirector
Patents
- Bacteriocin Production, Compositions and Methods of Useapplication
- Maltosyl-isomaltooligosaccharidesgranted
- Maltosyl-isomalto-oligosaccharides Reduce Symptoms Of Gastroesophageal Reflux Diseaseapplication
- Process For The Production Of Isomaltooligosaccharidesapplication
- Bacteriocin Production, Compositions and Methods of Usegranted
- Process For The Production Of Isomaltooligosaccharidesgranted
- Fermentative Process For The Manufacture Of Maltosyl-isomaltooligosaccharides (mimo)application
- Fermentative Process For The Manufacture Of Maltosyl-isomaltooligosaccharides (mimo)granted
- Maltosyl-isomaltooligosaccharidesgranted
- Maltosyl-isomaltooligosaccharidesgranted
- Process For The Manufacture Of Maltosyl-isomaltooligosaccharides (mimo)application
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.